A kinetic study of the oxidation effects of amphotericin B on human low-density lipoproteins

被引:20
作者
Barwicz, J [1 ]
Gruda, I [1 ]
Tancrède, P [1 ]
机构
[1] Univ Quebec, Dept Chim Biol, Trois Rivieres, PQ G9A 5H7, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
oxidation; low-density lipoprotein; amphotericin B; fungizone; AmBisome;
D O I
10.1016/S0014-5793(99)01731-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The UV-visible results of this kinetic study show that amphothericin B as Fungizone is a much stronger oxidant than CuSO4, itself a powerful oxidant of low-density lipoprotein (LDL), Amphotericin B as AmBisome alone has no oxidizing effect on LDL while a mixture of both AmBisome and CuSO4 induces an important potentialization of the LDL oxidation. These results allow us to believe that the high toxicity of amphotericin B is related to its capacity to modify and to weaken the structure of LDL. In addition, differential scanning calorimetry experiments show that the oxidative modifications of LDL by CuSO4 or by amphotericin B proceed through different mechanisms. (C) 2000 Federation of European Biochemical Societies.
引用
收藏
页码:83 / 86
页数:4
相关论文
共 23 条
[1]   Modification of the lipid-protein interaction in human low-density lipoprotein destabilizes ApoB-100 and decreases oxidizability [J].
Abuja, PM ;
Lohner, K ;
Prassl, R .
BIOCHEMISTRY, 1999, 38 (11) :3401-3408
[2]   AMPHOTERICIN B-INDUCED DILATED CARDIOMYOPATHY [J].
ARSURA, EL ;
ISMAIL, Y ;
FREEDMAN, S ;
KARUNAKAR, ARSR .
AMERICAN JOURNAL OF MEDICINE, 1994, 97 (06) :560-562
[3]   INHIBITION OF THE INTERACTION BETWEEN LIPOPROTEINS AND AMPHOTERICIN-B BY SOME DELIVERY SYSTEMS [J].
BARWICZ, J ;
GAREAU, R ;
AUDET, A ;
MORISSET, A ;
VILLIARD, J ;
GRUDA, I .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 181 (02) :722-728
[4]  
Barwicz J, 1998, BIOSPECTROSCOPY, V4, P135, DOI 10.1002/(SICI)1520-6343(1998)4:2<135::AID-BSPY6>3.0.CO
[5]  
2-4
[6]   AMPHOTERICIN-B OVERDOSE IN PEDIATRIC-PATIENTS WITH ASSOCIATED CARDIAC-ARREST [J].
CLEARY, JD ;
HAYMAN, J ;
SHERWOOD, J ;
LASALA, GP ;
PIAZZAHEPP, T .
ANNALS OF PHARMACOTHERAPY, 1993, 27 (06) :715-719
[7]   HPLC METHOD FOR QUANTITATION OF CHOLESTEROL AND 4 OF ITS MAJOR OXIDATION-PRODUCTS IN MUSCLE AND LIVER-TISSUES [J].
CSALLANY, AS ;
KINDOM, SE ;
ADDIS, PB ;
LEE, JH .
LIPIDS, 1989, 24 (07) :645-651
[8]   THE ROLE OF LIPID-PEROXIDATION AND ANTIOXIDANTS IN OXIDATIVE MODIFICATION OF LDL [J].
ESTERBAUER, H ;
GEBICKI, J ;
PUHL, H ;
JURGENS, G .
FREE RADICAL BIOLOGY AND MEDICINE, 1992, 13 (04) :341-390
[9]  
Hatch F T, 1968, Adv Lipid Res, V6, P1
[10]   OXIDATION OF LOW-DENSITY-LIPOPROTEIN BY HYPOCHLORITE CAUSES AGGREGATION THAT IS MEDIATED BY MODIFICATION OF LYSINE RESIDUES RATHER THAN LIPID OXIDATION [J].
HAZELL, LJ ;
VANDENBERG, JJM ;
STOCKER, R .
BIOCHEMICAL JOURNAL, 1994, 302 :297-304